Auro Pharmacies Recalls Calcium Gluconate Injectable Due to Sterility Concerns
Auro Pharmacies is recalling 167 vials of Calcium Gluconate injectable because processes and equipment were inadequate to assure sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a sterile injectable product with inadequate sterility assurance, which poses a risk of serious infection or injury, meeting the criteria for a Severe rating.
Plain-English summary
Auro Pharmacies, Inc. is recalling 167 vials of Calcium Gluconate injectable, 10%, 50 ml Single Dose vial, Rx only. The product was manufactured by Central Drugs Compounding Pharmacy, located at 520 W. La Habra Blvd, La Habra, CA 90631. The specific lot number is 180626/10, with an expiration date of 24-Sep-18.
The recall was initiated due to a lack of assurance of sterility. The source text states that there were inadequate processes and equipment to assure the sterility of products intended to be sterile. This is an FDA Class II recall, which indicates a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences.
The product was distributed nationwide in the USA. Consumers and healthcare providers should check their inventory for this specific lot number and expiration date. If found, the product should not be used and should be returned to the distributor or disposed of according to local regulations.
The recalled product
- Product
- Calcium Gluconate injectable, 10%, 50 ml Single Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631
- Manufacturer
- Auro Pharmacies, Inc.
- Category
- Drug — Injectable
- Affected units
- 167
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 180626/10
- Exp 24-Sep-18
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 12 recalled by Auro Pharmacies, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · Auro Pharmacies, Inc.
See all →- SevereAuro Pharmacies Recalls Folic Acid Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Testosterone Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Methyl-Cobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Testosterone Enanthate/Cypionate Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- SevereAuro Pharmacies Recalls Glutathione Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22